Paclitaxel 25021-0255-17
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA207326
Need to source Paclitaxel? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Paclitaxel | 6 mg/mL |
Drug Class
Microtubule Inhibitor [EPC]Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]
Selected Package
25021-0255-17Selected1 VIAL in 1 CARTON (25021-255-17) / 16.7 mL in 1 VIAL
Other packages for this product(2)
1 VIAL in 1 CARTON (25021-255-05) / 5 mL in 1 VIAL
1 VIAL in 1 CARTON (25021-255-50) / 50 mL in 1 VIAL